The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.

Item

http://www.wikidata.org/entity/Q33426787

Q33426787

about

From hypertension to stroke: mechanisms and potential prevention strategies.Misdiagnosis and mistreatment of a common side-effect--angiotensin-converting enzyme inhibitor-induced cough.Red yeast rice induces less muscle fatigue symptom than simvastatin in dyslipidemic patients: a single center randomized pilot trial.Complications of diabetes: progress, but significant challenges ahead.Complementary mechanisms of action and rationale for the fixed combination of perindopril and indapamide in treating hypertension - update on clinical utility The evolution and refinement of traditional risk factors for cardiovascular disease.Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model Tailored therapy of ACE inhibitors in stable coronary artery disease: pharmacogenetic profiling of treatment benefit.Perindopril for the treatment of hypertension.Genetic influences of angiotensin-converting enzyme inhibitor response: an opportunity for personalizing therapy?Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.Perindopril vs Enalapril in Patients with Systolic Heart Failure: Systematic Review and Metaanalysis.The Treatment Effect of an ACE-Inhibitor Based Regimen with Perindopril in Relation to Beta-Blocker use in 29,463 Patients with Vascular Disease: a Combined Analysis of Individual Data of ADVANCE, EUROPA and PROGRESS Trials.Unraveling the Pivotal Role of Bradykinin in ACE Inhibitor Activity.The Results of ACES (Antihypertensive Combinations' Long Term Efficacy Comparing Study): Analysis of Metabolic Effects of Antihypertensive Combination Therapies.Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study.Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.The effects of antitussive treatment of ACE inhibitor-induced cough on therapy compliance: a prescription sequence symmetry analysis.Commentary: Carotid Artery Revascularization for Stroke Prevention: A New Era.Vers de nouvelles cibles de traitement pour l’hypertension artérielle ?

P2860

Q30407495-56C4BEB1-E25F-44B3-88E6-BD03A99568A3 Q33668247-D8ADFF21-FB4F-46D1-9545-E6C7B7A46ABB Q33706945-5851FB61-4D03-475C-8F89-10B566D8BC1F Q34658375-2779BC6B-8065-480F-89A6-99A6A33FFA61 Q35210527-E4DB9614-FBDB-4CB7-AA47-F7F4C7332D5B Q35848359-72081E96-15E1-4CB2-A92B-36BAD229F458 Q37090714-85E07C35-C0C6-49F4-A5F7-4C75F26ACF6F Q37265528-6FE0C908-5E00-4642-89B6-79B5E2E2AB07 Q37780221-FEB5B427-83E6-400D-9322-5EA6DEEC801F Q37877722-30BAC178-2A42-48DD-80AC-1A9A17491A85 Q38048836-E7DD10C8-8C00-4EC9-BF16-FF012F1A2D4F Q38128175-02E90089-97FE-4E0B-B264-981C1172D7AC Q38253622-42ABF3E8-2FD8-46AA-AE38-DEDE45951795 Q38601013-DE5329E6-8E69-48DE-B69E-3CAFDEE12F61 Q38853318-AE988D6F-4CA7-4B14-ACC2-7E9891B849A4 Q39609055-A4CAFA42-7E5C-40DB-B101-89652A5C324D Q40030820-D6E80687-6A2A-47F6-A2E6-66AACD6A40F9 Q43031194-5D40779B-91F7-401F-8DF4-53CD85FE3B7D Q44833737-799D4773-BE1E-43A5-99E0-39397AAEDDBD Q51139784-613E9C90-331B-4725-B3D3-F3D6BFAC4538 Q57817344-61BD12F0-4063-4C41-851B-23127F080943

P2860

The consistency of the treatment effect of an ACE-inhibitor based treatment regimen in patients with vascular disease or high risk of vascular disease: a combined analysis of individual data of ADVANCE, EUROPA, and PROGRESS trials.

Item

http://www.wikidata.org/entity/Q33426787

description

2009 nî lūn-bûn

@nan

2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue